These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 17142808)

  • 41. Tools to explore ABCA3 mutations causing interstitial lung disease.
    Wittmann T; Schindlbeck U; Höppner S; Kinting S; Frixel S; Kröner C; Liebisch G; Hegermann J; Aslanidis C; Brasch F; Reu S; Lasch P; Zarbock R; Griese M
    Pediatr Pulmonol; 2016 Dec; 51(12):1284-1294. PubMed ID: 27177387
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic disorders of surfactant dysfunction.
    Wert SE; Whitsett JA; Nogee LM
    Pediatr Dev Pathol; 2009; 12(4):253-74. PubMed ID: 19220077
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pulmonary abnormalities due to ABCA1 deficiency in mice.
    Bates SR; Tao JQ; Collins HL; Francone OL; Rothblat GH
    Am J Physiol Lung Cell Mol Physiol; 2005 Dec; 289(6):L980-9. PubMed ID: 16055479
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human ABCA3, a product of a responsible gene for abca3 for fatal surfactant deficiency in newborns, exhibits unique ATP hydrolysis activity and generates intracellular multilamellar vesicles.
    Nagata K; Yamamoto A; Ban N; Tanaka AR; Matsuo M; Kioka N; Inagaki N; Ueda K
    Biochem Biophys Res Commun; 2004 Nov; 324(1):262-8. PubMed ID: 15465012
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cryo-EM structures of the human surfactant lipid transporter ABCA3.
    Xie T; Zhang Z; Yue J; Fang Q; Gong X
    Sci Adv; 2022 Apr; 8(14):eabn3727. PubMed ID: 35394827
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Calcineurin/Nfat signaling is required for perinatal lung maturation and function.
    Davé V; Childs T; Xu Y; Ikegami M; Besnard V; Maeda Y; Wert SE; Neilson JR; Crabtree GR; Whitsett JA
    J Clin Invest; 2006 Oct; 116(10):2597-609. PubMed ID: 16998587
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fatal familial lung disease caused by ABCA3 deficiency without identified ABCA3 mutations.
    Gower WA; Wert SE; Ginsberg JS; Golan A; Whitsett JA; Nogee LM
    J Pediatr; 2010 Jul; 157(1):62-8. PubMed ID: 20304423
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neonatal respiratory insufficiency caused by an (homozygous) ABCA3-stop mutation: a systematic evaluation of therapeutic options.
    Winter J; Essmann S; Kidszun A; Aslanidis C; Griese M; Poplawska K; Bartsch M; Schmitz G; Mildenberger E
    Klin Padiatr; 2014 Apr; 226(2):53-8. PubMed ID: 24633979
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An intronic ABCA3 mutation that is responsible for respiratory disease.
    Agrawal A; Hamvas A; Cole FS; Wambach JA; Wegner D; Coghill C; Harrison K; Nogee LM
    Pediatr Res; 2012 Jun; 71(6):633-7. PubMed ID: 22337229
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The biology of the ABCA3 lipid transporter in lung health and disease.
    Beers MF; Mulugeta S
    Cell Tissue Res; 2017 Mar; 367(3):481-493. PubMed ID: 28025703
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel synonymous ABCA3 variant identified in a Chinese family with lethal neonatal respiratory failure.
    Zhang W; Liu Z; Lin Y; Wang R; Xu J; He Y; Zhang F; Wu L; Chen D
    BMC Med Genomics; 2021 Oct; 14(1):256. PubMed ID: 34715861
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Respiratory syncytial virus potentiates ABCA3 mutation-induced loss of lung epithelial cell differentiation.
    Kaltenborn E; Kern S; Frixel S; Fragnet L; Conzelmann KK; Zarbock R; Griese M
    Hum Mol Genet; 2012 Jun; 21(12):2793-806. PubMed ID: 22434821
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pulmonary surfactants and their role in pathophysiology of lung disorders.
    Akella A; Deshpande SB
    Indian J Exp Biol; 2013 Jan; 51(1):5-22. PubMed ID: 23441475
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inherited pulmonary surfactant metabolism disorders in Argentina: Differences between patients with SFTPC and ABCA3 variants.
    Balinotti JE; Mallie C; Maffey A; Colom A; Epaud R; de Becdelievre A; Fanen P; Delestrain C; Medín M; Teper A
    Pediatr Pulmonol; 2023 Feb; 58(2):540-549. PubMed ID: 36324278
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Surfactant lipidomics in healthy children and childhood interstitial lung disease.
    Griese M; Kirmeier HG; Liebisch G; Rauch D; Stückler F; Schmitz G; Zarbock R;
    PLoS One; 2015; 10(2):e0117985. PubMed ID: 25692779
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metabolic labelling of choline phospholipids probes ABCA3 transport in lamellar bodies.
    Li Y; Kinting S; Höppner S; Forstner ME; Uhl O; Koletzko B; Griese M
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Dec; 1864(12):158516. PubMed ID: 31473345
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fatal respiratory failure in a full-term newborn with two ABCA3 gene mutations: a case report.
    Ciantelli M; Ghirri P; Presi S; Sigali E; Vuerich M; Somaschini M; Ferrari M; Boldrini A; Carrera P
    J Perinatol; 2011 Jan; 31(1):70-2. PubMed ID: 21189475
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Null ABCA3 in humans: large homozygous ABCA3 deletion, correlation to clinical-pathological findings.
    Carrera P; Ferrari M; Presi S; Ventura L; Vergani B; Lucchini V; Cogo PE; Carnielli VP; Somaschini M; Tagliabue P
    Pediatr Pulmonol; 2014 Mar; 49(3):E116-20. PubMed ID: 24420869
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ABCA3-mediated choline-phospholipids uptake into intracellular vesicles in A549 cells.
    Matsumura Y; Sakai H; Sasaki M; Ban N; Inagaki N
    FEBS Lett; 2007 Jul; 581(17):3139-44. PubMed ID: 17574245
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetic disorders of surfactant homeostasis.
    Whitsett JA; Wert SE; Xu Y
    Biol Neonate; 2005; 87(4):283-7. PubMed ID: 15985750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.